期刊文献+

盐酸万古霉素治疗新生儿MRSE/MRSA败血症35例临床研究 被引量:4

下载PDF
导出
出处 《中国药物与临床》 CAS 2004年第11期884-885,共2页 Chinese Remedies & Clinics
  • 引文网络
  • 相关文献

参考文献4

二级参考文献13

共引文献141

同被引文献29

  • 1徐进,许静,李燕,赵幽燕,谭家风,徐英美,赵真龄.新生儿的万古霉素血药浓度监测及安全性评价[J].中国医院药学杂志,2007,27(9):1200-1203. 被引量:13
  • 2Lutsar I, Chazallon C, Carducci F I, et al. Current management of late onset neonatal bacterial sepsis in five European countries[J]. Eur J Pediatr, 2014,173(8): 997-1004.
  • 3Badran E F,Shamayleh A,Irshaid Y M. Pharmacokinetics of vancomycin in neonates admitted to the neonatology unit at the Jordan University Hospita[E]. Int J Clin Pharmacol Ther,2011,49(4) :252-257.
  • 4Gwee A, Cranswick N, Metz D,et al. Neonatal vancomycin continuous infusion: still a confusion? [J] Pediatr Infect Dis J,2014,33(6) :600-605.
  • 5Kocher S,Muller W, Resch B. Linezolid treatment of nosocomialbacterial infection with multiresistant Gram-positive pathogens inpreterm infants: a systematic reviewf J]. Int J Antimicrob Agents,2010, 36 ( 2 ): 106-110. DOI: 10.1016/j. ijantimicag. 2010. 03. 030.
  • 6Itani KM, Biswas P, Reisman A, et al. Clinical efficacy of orallinezolid compared with intravenous vancomycin for the treatmentof methicillin resistant Staphylococcus aureus -complicated skin andsoft tissue infections : a retrospective, propensity score-matched,case-control analysis [ J ] . Clinical Therapeutics,2012, 34 ( 8 ):1667-1673. DOI: 10. 1016/j. clinthera. 2012. 06. 018.
  • 7Simon A, Mullenbom E, Prelog M, et al. Use of linezolid inneonatal and pediatric inpatient facilities-results of a retrospectivemulticenter survey[ J]. Eur J Clin Microbiol Infect Dis,2012,31(7);1435-1442. DOI: 10- 1007/sl0096-011-1461-l.
  • 8Vandendriessche A,Allegaert K,Cossey V,et al. Prospectivevalidation of neonatal vancomycin dosing regimens is urgentlyneeded[ J] . Curr Ther Res Clin Exp, 2014, 76: 51-57. DOI:10. 1016/j. curtheres. 2014. 06. 001.
  • 9Ringenberg T, Robinson C, Meyers R, et al. Achievement oftherapeutic vancomycin trough serum concentrations with empiricclosing in neonatal intensive care unit patients [ J ]. Pediatr InfectDis J, 2015, 34 ( 7 ): 742-747. DOI: 10.1097/INF. 0000000000000664.
  • 10Takahashi Y,Takesue Y, Nakajima K, et al. Risk factorsassociated with the development of thrombocytopenia in patientswho received linezolid therapy [ J]. J Infect Chemother,2011,17(3):382-387. DOI: 10. 1007/sl0156-010-0182-l.

引证文献4

二级引证文献41

;
使用帮助 返回顶部